Arvee Laboratories (India) Ltd
ARVEE
Company Profile
Business description
Arvee Laboratories (India) Ltd is a specialty chemical company. Its products include Polymer Modifiers, such as dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, and others, Contrast Media Intermediates such as Dimethyl 5-Aminoisophthalate, 3,5-Diamino Benzoic Acid, 5-Nitroisophthalic acid and others; and Drug Intermediates like 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde and others. Geographically, the company principally operates in India.
Contact
Iskcon Bopal Road
403, Entice Building
Opposite Jayantilal Park BRTS Bus Stop
Ambli
AhmedabadGJ380058
INDT: +91 2717430479
Sector
Basic Materials
Stock type
Cyclical
Industry
Specialty Chemicals
Fiscal Year End
31 March 2027
Employees
70
Stocks News & Analysis
stocks
Earnings margins to improve for mining specialist
Premium products drive margins yet shares fully valued.
stocks
Nvidia: Hugging Face acquisition both a wise offensive and defensive move
We think this improves Nvidia’s position within the open-source community.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,200.60 | 12.10 | -0.13% |
| CAC 40 | 8,285.67 | 6.90 | 0.08% |
| DAX 40 | 25,983.97 | 62.43 | -0.24% |
| Dow JONES (US) | 53,414.25 | 271.86 | -0.51% |
| FTSE 100 | 10,815.59 | 15.50 | -0.14% |
| HKSE | 25,413.12 | 237.75 | -0.93% |
| NASDAQ | 26,506.99 | 77.07 | -0.29% |
| Nikkei 225 | 66,399.84 | 1,378.90 | 2.12% |
| NZX 50 Index | 13,942.83 | 31.35 | -0.22% |
| S&P 500 | 7,718.60 | 29.11 | -0.38% |
| S&P/ASX 200 | 9,010.90 | 12.50 | -0.14% |
| SSE Composite Index | 3,932.70 | 2.58 | 0.07% |